Keyphrases
Blood-based
100%
Colonoscopy
95%
Colorectal Cancer
65%
Triage
51%
Colorectal Neoplasms
49%
Early Detection
49%
Colorectal Cancer Screening
48%
Cell-free DNA (cfDNA)
41%
Population Screening
37%
Bowel
36%
Blood Biomarkers
34%
Cancer-related
31%
Biomarker Testing
30%
Cancer-associated Proteins
30%
BCAT1
24%
Age-stratified
24%
Healthy Individuals
24%
IKZF1
24%
Fecal Immunochemical Test
24%
Interferon Regulatory Factor 4 (IRF4)
24%
Patients with Colorectal Cancer
24%
Handling Process
24%
Clinical Potential
24%
Poor Outcome
24%
Ferritin
24%
Blood Collection
24%
Tumor-specific
24%
Bowel Preparation
24%
Methylated DNA
24%
Fecal Occult Blood Test
22%
CYFRA 21-1
22%
Screening Population
22%
Training Set
18%
High-sensitivity C-reactive Protein (hs-CRP)
17%
Hemoglobin
16%
Galectin-3 (Gal-3)
15%
Colonoscopy Capacity
14%
BAGEL4
14%
Biomarker Signature
12%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
11%
Follow-up Colonoscopy
11%
Time Latency
11%
Major Clinical Study
11%
Waiting List
11%
Triage Test
11%
Feces
11%
Follow-up Examination
11%
Capacity Constraints
11%
Blood Samples
9%
Neoplasia
8%
Medicine and Dentistry
Colonoscopy
63%
Triage
49%
Colorectal Cancer
48%
Biological Marker
40%
Colorectal Tumor
24%
Specific Tumor
24%
Interferon Regulatory Factor 4
24%
DNA Methylation
24%
Mass Screening
20%
Malignant Neoplasm
19%
Polymerase Chain Reaction
8%
Carcinoembryonic Antigen
8%
Ferritin
8%
Neoplasm
8%
Colorectal Cancer Screening
8%
Adenoma
8%
Feces
7%
Drug Rapid Test
7%
Clinical Study
7%
Methylation
6%
Nursing and Health Professions
Colonoscopy
74%
Triage
51%
Malignant Neoplasm
40%
Colorectal Cancer
32%
Occult Blood Test
24%
Biological Marker
24%
Occult Blood
15%
Mass Screening
11%
Drug Rapid Test
7%
Hospital Admission
7%
Latent Period
7%